Package Leaflet: Information for the Patient
Dronedarone Aristo 400 mg Film-Coated Tablets
dronedarone
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Dronedarona Aristo contains an active ingredient called dronedarone. It belongs to a group of medications known as antiarrhythmics that help regulate your heart rhythm.
Dronedarona Aristo is used if you have a problem with your heart rhythm (atrial fibrillation: your heart beats irregularly) and a treatment called cardioversion has returned your heart rhythm to normal. Dronedarona Aristo prevents your irregular heart rhythm problem from recurring.
Your doctor will consider all possible treatment options before prescribing Dronedarona Aristo.
Do not take Dronedarona:
If you can be attributed to any of the above situations, do not take Dronedarona Aristo.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dronedarona Aristo if
While taking Dronedarona Aristo, inform your doctor if:
If you can be attributed to any of the above situations (or are unsure), consult your doctor or pharmacist before taking Dronedarona Aristo.
Blood tests, cardiac and pulmonary tests
While taking Dronedarona Aristo, your doctor may perform tests to check your health status and the effect the medication is having on you.
In some cases, it may be necessary to interrupt treatment with Dronedarona Aristo. Inform any other person who analyzes your blood that you are taking Dronedarona Aristo.
Use in children and adolescents
Dronedarona Aristo is not recommended for children and adolescents under 18 years old.
Taking Dronedarona Aristo with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. Your doctor may recommend a medication to prevent blood clots in the blood according to your clinical condition.
Dronedarona Aristo and other medications may interact and cause severe adverse effects. Your doctor may change the dose of other medications you are taking.
You should not take any of the following medications with Dronedarona Aristo:
You should consult your doctor or pharmacist if you are taking any of the following medications:
Taking Dronedarona Aristo with food and drinks
Do not drink grapefruit juice while taking Dronedarona Aristo. It may increase the levels of dronedarona in the blood and increase the risk of adverse effects.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before taking this medication.
Dronedarona Aristo is not recommended if you are pregnant or think you may be pregnant.
Do not take Dronedarona Aristo if you are a woman who may become pregnant and are not using a safe contraceptive method.
Stop taking your tablets and talk to your doctor immediately if you become pregnant while taking Dronedarona Aristo.
If you are breastfeeding, you should consult your doctor before taking Dronedarona Aristo.
Driving and using machines
Dronedarona Aristo usually does not affect your ability to drive and use machines. However, your ability to drive and use machines may be affected by adverse effects such as fatigue (if it appears).
Dronedarona Aristo contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
The treatment with Dronedarona Aristo must be supervised by a doctor with experience in the treatment of heart disease.
Follow exactly the administration instructions of this medication indicated by your doctor. If in doubt, ask your doctor or pharmacist.
If you need to change from amiodarone (another medication for irregular heartbeat) to Dronedarona Aristo, your doctor will make this change with caution.
How much to take
The usual dose is one 400 mg tablet twice a day. Take:
If you think your medication may have too strong or too weak an effect, consult with your doctor or pharmacist.
How to take this medication
Swallow the tablet whole with water during a meal. The tablet cannot be divided into equal doses.
If you take more Dronedarona Aristo than you should
Contact your doctor immediately, or the nearest emergency service or hospital. Bring the packaging of this medication. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Dronedarona Aristo
Do not take a double dose to compensate for the missed doses. Take the next dose when you normally do.
If you interrupt treatment with Dronedarona Aristo
Do not stop taking this medication without first talking to your doctor or pharmacist.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
The following side effects have been reported with this medicine:
Contact your doctor immediately if you notice any of the following serious side effects – as you may need urgent medical assistance.
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Other side effects
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the blister pack after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Do not use this medication if you notice any visible signs of deterioration (see section 6).
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need atthe SIGRE Collection Pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Appearance of the product and contents of the package
Dronedarone Aristo is a white-coated, oval-shaped tablet with dimensions of 17.6 mm x 8.1 mm.
Blister packs of PVC/Aluminum or opaque PVC / PE / PVDC-Aluminum in packages of 20, 40, 50, 60, and 100 coated tablets.
Dronedarone Aristo is available in packages of 20, 20x1, 40, 40x1, 50, 50x1, 60, 60x1, 100, and 100x1 coated tablets in blisters and perforated single-dose blisters.
Only some package sizes may be commercially available.
Marketing authorization holder
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Rontis Hellas Medical and Pharmaceutical Products S.A.
P.O. Box 3012 Larissa Industrial Area,
41500 Larissa,
Greece
Responsible manufacturer
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid. Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Germany:Dronedaron Aristo 400 mg Filmtabletten
Austria:Dronedaron Aristo 400 mg Filmtabletten
Denmark:Dronedaron Aristo
Norway:Dronedaron Aristo
Sweden:Dronedaron Aristo
Italy:Dronedarone Aristo
Hungary:Dronedaron Aristo 400 mg filmtabletta
United Kingdom:Dronedarone Aristo 400 mg film-coated tablets
Spain:Dronedarona Aristo 400 mg comprimidos recubiertos con película EFG
Last review date of this leaflet: September 2020
More detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.